Teva Pharmaceuticals
TEVA
TEVA
818 hedge funds and large institutions have $30.6B invested in Teva Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 260 increasing their positions, 327 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $32.5B → $30.6B (-$1.96B)
20% less repeat investments, than reductions
Existing positions increased: 260 | Existing positions reduced: 327
33% less funds holding in top 10
Funds holding in top 10: 70 → 47 (-23)
Holders
818
Holding in Top 10
47
Calls
$692M
Puts
$508M
Top Buyers
| 1 | +$527M | |
| 2 | +$216M | |
| 3 | +$168M | |
| 4 |
SIG
Senator Investment Group
New York
|
+$136M |
| 5 |
PC
Paulson & Co
New York
|
+$120M |
Top Sellers
| 1 | -$395M | |
| 2 | -$326M | |
| 3 | -$291M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$187M |
| 5 |
Lazard Asset Management
New York
|
-$148M |